Leading Biotech Company Secures U.S. Patent For Major ADHD Treatment

ABVC BioPharma Secures New US Patent for ADHD Treatment: An Urgent Breakthrough.

(This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.)

ABVC BioPharma, a leading biopharmaceutical company, has recently received a significant US patent, No: 12/120,965, for the use of PDC-1421 in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). This break…